Genflow Biosciences hails data from trial of dog ageing gene therapy
(Alliance News) - Genflow Biosciences PLC on Friday reported strong data from a proof-of-concept clinical trial of its proprietary SIRT6-centenarian gene therapy for age-related decline in elderly dogs. Read More